ITPN20110060A1 - INFORMATION SYSTEM FOR PHARMACEUTICAL ADMINISTRATION MONITORING - Google Patents
INFORMATION SYSTEM FOR PHARMACEUTICAL ADMINISTRATION MONITORING Download PDFInfo
- Publication number
- ITPN20110060A1 ITPN20110060A1 IT000060A ITPN20110060A ITPN20110060A1 IT PN20110060 A1 ITPN20110060 A1 IT PN20110060A1 IT 000060 A IT000060 A IT 000060A IT PN20110060 A ITPN20110060 A IT PN20110060A IT PN20110060 A1 ITPN20110060 A1 IT PN20110060A1
- Authority
- IT
- Italy
- Prior art keywords
- pharmaceutical
- patient
- computing device
- administrations
- risk
- Prior art date
Links
- 238000012544 monitoring process Methods 0.000 title claims description 4
- 206010067484 Adverse reaction Diseases 0.000 claims description 27
- 230000006838 adverse reaction Effects 0.000 claims description 27
- 238000000034 method Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 6
- 230000011664 signaling Effects 0.000 claims description 5
- 238000001647 drug administration Methods 0.000 claims description 3
- 238000009434 installation Methods 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 claims description 2
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 230000005540 biological transmission Effects 0.000 claims description 2
- 230000003287 optical effect Effects 0.000 claims description 2
- 230000006461 physiological response Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000642 iatrogenic effect Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010013710 Drug interaction Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000011970 concomitant therapy Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000012854 evaluation process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000002974 pharmacogenomic effect Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/08—Logistics, e.g. warehousing, loading or distribution; Inventory or stock management
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Business, Economics & Management (AREA)
- Public Health (AREA)
- Economics (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Operations Research (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Business, Economics & Management (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Strategic Management (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tourism & Hospitality (AREA)
- Quality & Reliability (AREA)
- Marketing (AREA)
- Human Resources & Organizations (AREA)
- Entrepreneurship & Innovation (AREA)
- Development Economics (AREA)
- Biomedical Technology (AREA)
- Data Mining & Analysis (AREA)
- Databases & Information Systems (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Description
"Sistema informatico di monitoraggio di somministrazioni farmaceutiche" "Computer system for monitoring pharmaceutical administrations"
Testo della descrizione Description text
La presente invenzione concerne un sistema informatico di monitoraggio di somministrazioni farmaceutiche. The present invention relates to a computer system for monitoring pharmaceutical administrations.
STATO DELLA TECNICA STATE OF THE TECHNIQUE
Il sistema nasce da un'osservazione di farmacovigilanza evidence based: vi à ̈ un'oggettiva difficoltà per il medico specialista nella gestione del background farmacologico del paziente. Due sono i momenti di criticità : la prima visita e l’atto dimissivo. The system arises from an observation of evidence based pharmacovigilance: there is an objective difficulty for the specialist doctor in managing the patient's pharmacological background. There are two critical moments: the first visit and the discharge.
La problematica à ̈ adducibile a due meccanismi: da un lato il malato non à ̈ in grado di comprendere il reale pericolo che incontra sotto il profilo tossicologico seguendo una terapia che prevede la somministrazione concomitante di più farmaci. La seconda questione riguarda il sic volo: lo specialista non può prendere in carico la responsabilità di terapie concomitanti per patologie cronico – degenerative normalmente di pertinenza del medico di famiglia. The problem can be attributed to two mechanisms: on the one hand, the patient is unable to understand the real danger he encounters from a toxicological point of view following a therapy that involves the concomitant administration of several drugs. The second issue concerns the sic flight: the specialist cannot take responsibility for concomitant therapies for chronic - degenerative diseases normally pertaining to the family doctor.
Attualmente le interazioni farmacologiche provocano la morte del paziente nel 19% dei casi rilevati e costano ai sistemi sanitari mondiali più di 3 miliardi di dollari all’anno. Questo perché tra una visita specialistica e quella successiva possono intercorrere anche diversi mesi. Si crea così un gap che può condurre a gravi rischi di danno iatrogeno – che chiaramente debbono essere minimizzati – e si inizia ad instaurare nel paziente una sensazione di abbandono alla propria malattia. Drug interactions currently cause patient death in 19% of detected cases and cost world health systems more than $ 3 billion a year. This is because several months can elapse between a specialist visit and the next one. A gap is thus created that can lead to serious risks of iatrogenic damage - which clearly must be minimized - and a feeling of abandonment to their illness begins to establish in the patient.
Per ovviare a tali inconvenienti ed ottenere altri ed ulteriori vantaggi, il Richiedente ha studiato e realizzato il presente trovato. To obviate these drawbacks and obtain other and further advantages, the Applicant has studied and implemented the present invention.
ESPOSIZIONE DEL TROVATO EXPOSURE OF THE FOUND
Ogni paziente che usa il sistema viene messo in relazione – tramite un tesserino con i propri dati identificativi – con la lista dei farmaci che ha assunto. Ciò permette al medico mediante l'utilizzo di un terminale da banco di conoscere il background farmaceutico del paziente già in prima visita. Inoltre il sistema coinvolge anche altri attori, quali le farmacie territoriali e le case di riposo, che possono segnalare la vendita e somministrazione dei farmaci in modo trasparente e automatico mediante un terminale da banco. Il sistema in questo modo favorisce la diffusione di un network di collaborazione altamente specialistico senza gravare di ulteriori oneri medici e farmacisti. Each patient who uses the system is put in relation - through a card with their identification data - with the list of drugs they have taken. This allows the doctor through the use of a counter terminal to know the patient's pharmaceutical background already in the first visit. Furthermore, the system also involves other actors, such as local pharmacies and nursing homes, which can report the sale and administration of drugs in a transparent and automatic way through a counter terminal. In this way, the system favors the spread of a highly specialized collaboration network without burdening additional medical and pharmacist burdens.
In base alle informazioni così raccolte da un sistema centrale di computazione, il sistema à ̈ in grado di costruire il background farmacologico del paziente, cioà ̈ tutti quei farmaci che il paziente assume durante la cura attraverso diverse sorgenti (ospedale, farmacia, medico di base, specialista…). Nel caso in cui venisse riscontrata la possibilità di una reazione avversa di tipo iatrogeno – in base alla gravità – un dispositivo centrale di segnalazione avvisa il medico e il paziente, tramite SMS o contatto diretto di un operatore. Così facendo il paziente sarà consapevole di essere continuamente seguito e monitorato durante la sua terapia. Based on the information collected in this way by a central computation system, the system is able to build the patient's pharmacological background, i.e. all those drugs that the patient takes during treatment through different sources (hospital, pharmacy, base, specialist ...). In the event that the possibility of an adverse reaction of the iatrogenic type is detected - based on the severity - a central signaling device alerts the doctor and the patient, via SMS or direct contact with an operator. In doing so, the patient will be aware of being continuously followed and monitored during his therapy.
Infine l’implementazione informatizzata del servizio da noi proposta integra informazioni farmaco genomiche, informazioni sull’emivita e posologia delle sostanze, informazioni sui terminali da banco che hanno effettuato le segnalazioni di somministrazioni e informazioni su casi analoghi di reazioni avverse nel processo di valutazione del rischio iatrogeno e non richiede alcun intervento esterno da parte di medici, farmacisti e altri operatori sanitari poiché à ̈ totalmente automatica. Finally, the computerized implementation of the service proposed by us integrates drug-genomic information, information on the half-life and dosage of substances, information on the over-the-counter terminals that have reported administration and information on similar cases of adverse reactions in the evaluation process. of iatrogenic risk and does not require any external intervention by doctors, pharmacists and other health professionals as it is totally automatic.
MODELLO DI FUNZIONAMENTO MODEL OF OPERATION
A tempo zero il paziente si reca presso una struttura autorizzata all’uso del sistema e dotata di un terminale da banco (11). Al paziente viene consegnata un tesserino (21) in cui sono memorizzate, in forma elettronica, informazioni sull’identità individuale (22) del paziente stesso. Tale tesserino può essere anche già in possesso del paziente, a patto che rispetti i requisiti imposti dal sistema. Il paziente risulta così iscritto all’uso del sistema. At zero time the patient goes to a facility authorized to use the system and equipped with a bench terminal (11). The patient is given a card (21) in which information on the individual identity (22) of the patient is stored in electronic form. This card may also already be in the possession of the patient, as long as it complies with the requirements imposed by the system. The patient is thus registered to use the system.
A tempo maggiore di zero ed in corrispondenza ad una qualsiasi somministrazione farmaceutica da parte di una struttura autorizzata e dotata di un terminale da banco (11), il paziente esibirà il tesserino (21) ed un operatore autorizzato all’utilizzo del terminale da banco (11) provvederà ad effettuare il processo di segnalazione della somministrazione. Tale processo include la lettura del tesserino (21) mediante un lettore elettronico (13), il riconoscimento della somministrazione farmaceutica mediante un lettore ottico (12) – tipicamente ma non esclusivamente per mezzo di un codice a barre – e l’invio delle informazioni sulla somministrazione al dispositivo centrale di computazione (15) da parte di un personal computer (14) tipicamente ma non esclusivamente mediante una rete internet. At a time greater than zero and in correspondence with any pharmaceutical administration by an authorized facility equipped with a counter terminal (11), the patient will show the card (21) and an operator authorized to use the counter terminal (11) will carry out the administration reporting process. This process includes the reading of the card (21) by means of an electronic reader (13), the recognition of pharmaceutical administration by means of an optical reader (12) - typically but not exclusively by means of a bar code - and the ™ sending information on administration to the central computing device (15) by a personal computer (14) typically but not exclusively via an internet network.
Il dispositivo centrale di computazione (15) elabora tutte le segnalazioni ricevute dai vari terminali da banco (11) per ogni paziente che utilizza il sistema mediante il proprio tesserino (21). La lista delle somministrazioni farmaceutiche di ogni paziente costituisce il background farmaceutico del paziente (31). In base al background farmaceutico del paziente (31) – tipicamente ma non esclusivamente in corrispondenza di una nuova segnalazione da parte di un terminale da banco (11) – il dispositivo centrale di computazione (15) stima il rischio di reazioni avverse per quello specifico paziente includendo il seguente procedimento: The central computing device (15) processes all the signals received from the various counter terminals (11) for each patient who uses the system by means of his or her card (21). The list of each patient's drug administrations constitutes the patient's pharmaceutical background (31). Based on the patient's pharmaceutical background (31) - typically but not exclusively at a new report from a counter terminal (11) - the central computing device (15) estimates the risk of adverse reactions for that specific patient including the following procedure:
i. Sulla base del background farmaceutico sono individuate tutte le reazioni avverse sviluppabili dal paziente e note a priori in letteratura, mediante l’utilizzo di un database delle reazioni avverse ai farmaci, detto DRA (32) the. On the basis of the pharmaceutical background, all the adverse reactions that can be developed by the patient and known a priori in the literature are identified, through the use of a database of adverse drug reactions, called DRA (32)
ii. Ad ogni reazione avversa vengono associati un valore di rischio noto in letteratura (38) estratto dal suddetto DRA e le somministrazioni farmaceutiche coinvolte dalla reazione avversa ii. Each adverse reaction is associated with a risk value known in the literature (38) extracted from the aforementioned DRA and the pharmaceutical administrations involved in the adverse reaction
iii. Tale valore di rischio viene modificato secondo la posologia ed emivita delle somministrazioni farmaceutiche (33) coinvolte dalla reazione avversa, mediante l’utilizzo di un prontuario farmaceutico informatizzato iii. This risk value is modified according to the posology and half-life of the pharmaceutical administrations (33) involved in the adverse reaction, through the use of a computerized pharmaceutical handbook
iv. Tale valore di rischio viene modificato in base al luogo di installazione dei terminali da banco (34) che hanno effettuato la trasmissione delle somministrazioni farmaceutiche coinvolte dalla reazione avversa – tipicamente viene ridotto nel caso in cui sia stato lo stesso terminale da banco (11) ad effettuare le segnalazioni coinvolte dalla reazione avversa iv. This risk value is modified according to the place of installation of the bench terminals (34) that carried out the transmission of the pharmaceutical administrations involved in the adverse reaction - typically it is reduced if it was the same bench terminal (11 ) to make the reports involved in the adverse reaction
v. Tale valore di rischio viene modificato sulla base di informazioni farmaco genomiche (35) sulla risposta fisiologica del paziente rispetto alle somministrazioni farmaceutiche coinvolte dalla reazione avversa – tipicamente ma non necessariamente la velocità di assorbimento delle somministrazioni farmaceutiche coinvolte – ottenute da un sistema esterno. v. This risk value is modified on the basis of pharmaco-genomic information (35) on the physiological response of the patient with respect to the pharmaceutical administrations involved in the adverse reaction - typically but not necessarily the speed of absorption of the pharmaceutical administrations involved - obtained from a system external.
vi. Tale valore di rischio à ̈ modificato in base a informazioni su casi analoghi già trattati (36) basati sullo stesso paziente o su pazienti che hanno maturato la medesima reazione avversa – tipicamente ma non necessariamente da parte dello stesso medico curante. you. This risk value is modified based on information on similar cases already treated (36) based on the same patient or on patients who have experienced the same adverse reaction - typically but not necessarily by the same treating physician.
vii. Ogni valore di rischio così calcolato (37) à ̈ trasmesso, includendo le informazioni sulle somministrazioni farmaceutiche coinvolte dalla reazione avversa e le informazioni sull’identità individuale del paziente, al poi descritto sistema centrale di segnalazione (16) vii. Each risk value calculated in this way (37) is transmitted, including information on the pharmaceutical administrations involved in the adverse reaction and information on the patient's individual identity, to the then described central reporting system (16)
Il dispositivo centrale di segnalazione (16) à ̈ connesso al dispositivo centrale di computazione (15) ed effettua l’invio selettivo di allarmi a mezzo elettronico – tipicamente ma non necessariamente tramite messaggio SMS (17) – in base alla gravità delle reazioni avverse segnalate dal dispositivo centrale di computazione (15) descritte dal valore di rischio ricevuto (37). The central signaling device (16) is connected to the central computing device (15) and carries out the selective sending of alarms electronically - typically but not necessarily via SMS message (17) - based on the severity of adverse reactions reported by the central computing device (15) described by the risk value received (37).
ILLUSTRAZIONE DEI DISEGNI ILLUSTRATION OF DRAWINGS
La figura 1 illustra gli schemi di collegamento tra i terminali da banco (11), il dispositivo centrale di computazione (15) e il dispositivo centrale di segnalazione (16). Figure 1 illustrates the connection diagrams between the bench terminals (11), the central computing device (15) and the central signaling device (16).
La figura 2 mostra un tesserino (21) atto a contenere per via elettronica i dati identificativi (22) sull’identità individuale del paziente Figure 2 shows a card (21) designed to electronically contain the identification data (22) on the individual identity of the patient
La figura 3 mostra il procedimento di stima del rischio di reazioni avverse realizzato dal dispositivo centrale di computazione (15). Figure 3 shows the process of estimating the risk of adverse reactions carried out by the central computing device (15).
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000060A ITPN20110060A1 (en) | 2011-08-24 | 2011-08-24 | INFORMATION SYSTEM FOR PHARMACEUTICAL ADMINISTRATION MONITORING |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000060A ITPN20110060A1 (en) | 2011-08-24 | 2011-08-24 | INFORMATION SYSTEM FOR PHARMACEUTICAL ADMINISTRATION MONITORING |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITPN20110060A1 true ITPN20110060A1 (en) | 2011-11-23 |
Family
ID=44800163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT000060A ITPN20110060A1 (en) | 2011-08-24 | 2011-08-24 | INFORMATION SYSTEM FOR PHARMACEUTICAL ADMINISTRATION MONITORING |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | ITPN20110060A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003046789A1 (en) * | 2001-11-26 | 2003-06-05 | Pdx, Inc. | Automated system and method for processing prescriptions |
| US20060089856A1 (en) * | 2004-10-21 | 2006-04-27 | Cardiac Pacemakers | Integrated pharmaceutical dispensing and patient management monitoring |
| US20070214009A1 (en) * | 2005-10-05 | 2007-09-13 | Robert Epstein | System and method for clinical strategy for therapeutic pharmacies |
-
2011
- 2011-08-24 IT IT000060A patent/ITPN20110060A1/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003046789A1 (en) * | 2001-11-26 | 2003-06-05 | Pdx, Inc. | Automated system and method for processing prescriptions |
| US20060089856A1 (en) * | 2004-10-21 | 2006-04-27 | Cardiac Pacemakers | Integrated pharmaceutical dispensing and patient management monitoring |
| US20070214009A1 (en) * | 2005-10-05 | 2007-09-13 | Robert Epstein | System and method for clinical strategy for therapeutic pharmacies |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108172302A (en) | Rational use of medicines information monitoring method and system | |
| Sullivan et al. | Medication errors in pediatrics—the octopus evading defeat | |
| CN114008719A (en) | System and method for medication management | |
| Pote et al. | Medication prescribing errors in a public teaching hospital in India: A prospective study | |
| Ferner | An agenda for UK clinical pharmacology: Medication errors | |
| US20160328993A1 (en) | Location agnostic platform for medical condition monitoring and prediction and method of use thereof | |
| WO2020163465A1 (en) | Method and system for monitoring and controlling high risk substances | |
| JP2018523224A (en) | Game system and method for improving health management outcomes | |
| US20210098093A1 (en) | Integrated healthcare methods and systems | |
| Schorr et al. | Exploring the potential impact of hospital ward-based pharmacy interns on drug safety | |
| US20140006040A1 (en) | Home healthcare system including medication administration system and method of dispensing medicines | |
| ITPN20110060A1 (en) | INFORMATION SYSTEM FOR PHARMACEUTICAL ADMINISTRATION MONITORING | |
| CN205644653U (en) | Intelligent medical kit system of regional medical all -purpose card of collection | |
| Hudspeth | Safe opioid prescribing for adults by nurse practitioners: Part 2. Implementing and managing treatment | |
| Scott et al. | Integrating safety concepts in health and social care | |
| Munzner et al. | Measuring and describing dose omissions using an electronic medication management system | |
| Apu et al. | iMedMS: an IoT Based intelligent medication monitoring system for elderly healthcare | |
| Klimov et al. | iALARM: An intelligent alert language for activation, response, and monitoring of medical alerts | |
| CN113724891A (en) | Hospital epidemic situation monitoring method, device and related equipment | |
| Zafar et al. | Assessment of look‐alike, sound‐alike and read‐alike (LASARA) medicine‐errors in pharmacy | |
| Lucca et al. | A comprehensive monitoring of clozapine and related components in clinical practices. Saudi Arabian scenario | |
| US20160259892A1 (en) | System and method for managing drug dispensing to patients | |
| Cooper | Prescription drug monitoring programs and overdoses: Advancing the next generation of research | |
| JP2011039670A (en) | System and program for managing medicine | |
| Gottapu et al. | A REVIEW ON OBSTACLES AND PREVENTION OF DRUG RELATED PROBLEMS |